139 related articles for article (PubMed ID: 9273545)
21. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study.
Horny HP; Kaiserling E
Br J Haematol; 1988 Aug; 69(4):449-55. PubMed ID: 3408682
[TBL] [Abstract][Full Text] [Related]
22. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.
Chott A; Guenther P; Huebner A; Selzer E; Parwaresch RM; Horny HP; Valent P
Am J Surg Pathol; 2003 Jul; 27(7):1013-9. PubMed ID: 12826896
[TBL] [Abstract][Full Text] [Related]
23. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
[TBL] [Abstract][Full Text] [Related]
25. An unusual presentation of systemic mastocytosis.
Kennedy RJ; Scoffield JL; Garstin WI
J Clin Pathol; 1999 Apr; 52(4):301-2. PubMed ID: 10474524
[TBL] [Abstract][Full Text] [Related]
26. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
27. Aggressive systemic mastocytosis.
Inaoui R; Petit B; Jaccard A; Bertin P; Trèves R
Joint Bone Spine; 2003 Feb; 70(1):64-6. PubMed ID: 12639621
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
Escribano L; Díaz Agustín Beatriz ; Bravo P; Navalón R; Almeida J; Orfao A
Leuk Lymphoma; 1999 Oct; 35(3-4):227-35. PubMed ID: 10706445
[TBL] [Abstract][Full Text] [Related]
29. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
[TBL] [Abstract][Full Text] [Related]
30. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
31. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
32. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
[TBL] [Abstract][Full Text] [Related]
33. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
Akin C; Jaffe ES; Raffeld M; Kirshenbaum AS; Daley T; Noel P; Metcalfe DD
Am J Clin Pathol; 2002 Aug; 118(2):242-7. PubMed ID: 12162685
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
[TBL] [Abstract][Full Text] [Related]
35. Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells.
Horny HP
Am J Clin Pathol; 2009 Sep; 132(3):438-47. PubMed ID: 19687320
[TBL] [Abstract][Full Text] [Related]
36. Primary thrombocythaemia associated with systemic mastocytosis: a report of five cases.
Le Tourneau A; Gaulard P; D'Agay MF; Vainchencker W; Cadiou M; Devidas A; Haioun C; Clauvel JP; Audouin J; Diebold J
Br J Haematol; 1991 Sep; 79(1):84-9. PubMed ID: 1911390
[TBL] [Abstract][Full Text] [Related]
37. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
[TBL] [Abstract][Full Text] [Related]
38. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
40. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]